Sphincter of oddi dysfunction

Current Gastroenterology Reports

Volumn 12, Issue 2, 2010, Pages 130-134

  Baillie, John ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Biliary dyskinesia; Biliary microlithiasis; Biliary pain; Biliary sphincterotomy; Carnett's sign; CCK HIDA scan; Chemoprevention; Costochondritis; Gallbladder dyskinesia; Gastroparesis; Milwaukee criteria; Narcotic bowel; Post ERCP pancreatitis; Prophylactic pancreatic stent; Rome III classification; Secretin stimulated MRCP; Solid state manometry catheters; Sphincter of Oddi dysfunction; Trigger point; Vardenafil

Indexed keywords

BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CHOLECYSTOKININ; DIGLYCINE; GABEXATE; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; SOMATOSTATIN; VARDENAFIL;

ANAMNESIS; BILE DUCT PRESSURE; BILIARY MICROLITHIASIS; CHOLELITHIASIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NERVE INJURY; NON INVASIVE PROCEDURE; ODDI SPHINCTER DYSFUNCTION; PAIN; PANCREAS FUNCTION DISORDER; PANCREATITIS; PHYSICAL EXAMINATION; REVIEW; RISK BENEFIT ANALYSIS; STOMACH PARESIS; TIETZE SYNDROME; TIMED CHOLECYSTOKININ STIMULATED HEPATOBILIARY IMINODIACETIC ACID SCAN; CHEMOPROPHYLAXIS; CHOLECYSTECTOMY; ENDOSCOPIC SPHINCTEROTOMY; MANOMETRY; PRESSURE; PROCEDURES; PROGNOSIS; SPHINCTER OF ODDI DYSFUNCTION;

CHEMOPREVENTION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CHOLECYSTECTOMY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MANOMETRY; PRESSURE; PROGNOSIS; SPHINCTER OF ODDI DYSFUNCTION; SPHINCTEROTOMY, ENDOSCOPIC;

EID: 77955920390     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-010-0096-1     Document Type: Review

References (24)

1. JE Geenen WJ Hogan WJ Dodds, et al. 1989 The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction N Engl J Med 320 82 87 1:STN:280:DyaL1M%2FpslWjsA%3D%3D 2643038
2. J Toouli 2009 Sphincter of Oddi: function, dysfunction, and its management J Gastroenterol Hepatol 24 SUPPL. 3 S57 S62 10.1111/j.1440-1746.2009. 06072.x 19799700
3. J Behar E Corazziari M Guelrud, et al. 2006 Functional gallbladder and sphincter of Oddi disorders Gastroenterology 130 1498 1509 10.1053/j.gastro. 2005.11.063 16678563
4. Rome Foundation: Rome III diagnostic questionnaires. Available at http://www.romecriteria.org/questionnaires/. Accessed February 2010.
5. Ruffolo TA, Sherman S, Lehman, et al.: Gallbladder ejection fraction and its relationship to sphincter of Oddi dysfunction. Dig Dis Sci 1994, 39:289-292.
6. U Choudhry T Ruffolo P Jamidar, et al. 1993 Sphincter of Oddi dysfunction in patients with intact gallbladder: therapeutic response to endoscopic sphincterotomy Gastrointest Endosc 39 492 495 10.1016/S0016-5107(93)70157-1 1:STN:280:DyaK3sznsVaisA%3D%3D 8365594
7. ML Freeman NM Guda 2004 Prevention of post-ERCP pancreatitis: a comprehensive review Gastrointest Endosc 59 845 864 10.1016/S0016-5107(04)00353- 0 15173799
8. ML Freeman 2002 Post-ERCP pancreatitis: patient and technique-related risk factors JOP 3 169 176 12432183
9. AM Saad EL Fogel L McHenry, et al. 2008 Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results Gastrointest Endosc 67 255 261 10.1016/j.gie.2007.06.022 18028920
10. Freeman ML: Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007, 5:1354-1365. This article describes the role of pancreatic stents in the prevention of post-ERCP pancreatitis, as discussed by the pioneer in the field.
11. A Senol U Saritas H Demirkan 2009 Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis World J Gastroenterol 15 3999 4004 10.3748/wjg.15.3999 19705494
12. Elmunzer BJ, Waljee AK, Elta GH, et al.: A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008, 57:1262-1267. This article presents a meta-analysis of four prospective studies appearing to show that NSAIDs may significantly reduce the risk of post-ERCP pancreatitis.
13. M Staritz T Poralla HH Dormeyer, et al. 1985 Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilation Gastroenterology 88 1807 1811 1:STN:280:DyaL2M3gsFWmtg%3D%3D 3922844
14. L Madácsy G Kurucsai R Fejes, et al. 2009 Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis Dig Endosc 21 8 13 10.1111/j.1443-1661.2008.00819.x 19691794
15. ML Freeman 2007 Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis Clin Gastroenterol Hepatol 5 1354 1365 10.1016/j.cgh.2007.09.007 17981248
16. YK Cheon YD Cho JH Moon, et al. 2009 Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction Gastrointest Endosc 69 1111 1116 10.1016/j.gie.2008.07.014 19243765
17. J Affronti 2009 Levitra for sphincter of Oddi dysfunction? Are you kidding? Gastrointest Endosc 69 1117 1119 10.1016/j.gie.2008.10.006 19410043
18. Khashab MA, Watkins JL, McHenry Jr L, et al.: Frequency of sphincter of Oddi dysfunction in patients with previously normal sphincter of Oddi manometry studies. Endoscopy 2009 (Epub ahead of print).
19. PV Draganov L Kowalczyk CE Forsmark 2009 Prospective trial comparing solid-state catheter and water-perfusion triple-lumen catheter for sphincter of Oddi manometry done at the time of ERCP Gastrointest Endosc 70 92 95 10.1016/j.gie.2008.11.044 19386306
20. AM Aisen S Sherman SG Jennings, et al. 2008 Comparison of secretin-stimulated magnetic resonance pancreatography and manometry results in patients with suspected sphincter of Oddi dysfunction Acad Radiol 15 601 609 10.1016/j.acra.2007.12.009 18423317
21. J Baillie J Kimberly 2007 Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III Gut 56 742 744 10.1136/gut.2006.111278 17519477
22. Elmi F, Silverman WB: biliary sphincter of Oddi dysfunction type I versus occult biliary microlithiasis in post-cholecystectomy patients: are they both part of the same clinical entity? Dig Dis Sci 2009 (Epub ahead of print).
23. Sphincter of Oddi dysfunction (SOD). Available at http://sphincter-of- odii-sod.blogspot.com. Accessed February 2010.
24. S Cohen B Bacon JA Berlin, et al. 2002 National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002 Gastrointest Endosc 56 803 809 10.1016/S0016-5107(02)70351-9 12447289